On-demand webinar: Mitigating risk in mRNA manufacturing when transitioning from preclinical to clinical
Join Evan Myers, head of TriLink GMP services' process development team, as he discusses key challenges and solutions in the pivotal transition stages of mRNA manufacturing.
Key topics to be discovered:
- Understand how mRNA as a versatile platform for therapeutic and vaccine development holds immense promise in reshaping the landscape of molecular medicine.Â
- Learn about common challenges with preclinical and clinical transitions in mRNA manufacturingÂ
- Explore how to mitigate risk and streamline mRNA manufacturing across phases through scale-up, process robustness, and reproducibility
- Discover practical takeaways for researchers and developers working on mRNA technologies